Biomarkers for RA I read the article, “Finding Biomarkers in RA Remains Elusive Goal” (February 2015 The Rheumatologist), with great interest. The author correctly identifies the multi-biomarker disease activity assay (MBDA; Vectra DA) as a potential biomarker that identifies RA patients at risk for radiographic progression. The author names a study presented at the 2014…
Plaquenil: From Malaria Treatment to Managing Lupus, RA
In 1984, I wrote my first prescription for the antimalarial drug, hydroxychloroquine (Plaquenil), for a 28-year-old woman with SLE. She was considerably overweight, with inflammatory arthritis and a photosensitive rash, and I worried that oral corticosteroids would tip her over into diabetes. I presented the case to my attending, Steven Malawista, MD, at the Yale…
2014 ACR/ARHP Annual Meeting: Super Proteins Eyed in Therapies for Rheumatic Diseases
Immunoglobulin superfamily of proteins, CTLA-4 and PD-1, may generate treatments for RA, SLE
2014 ACR/ARHP Annual Meeting: Regulatory T Cells
Rheumatology experts explore ways Treg cells contribute to autoimmune diseases, RA
Rheumatoid Arthritis and Pregnancy
Research shows women with RA at risk of preterm birth
Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do
Lack of efficacy, poor DAS scores may be misinterpreted as a drug failure
Advice Rheumatologists Can Share with Patients Planning to Relocate, a Patient Perspective
Tips for stocking up on medications, providing comprehensive health history to new physicians and coping with stress
Patient’s Journey with Rheumatoid Arthritis Redefines ‘Treat to Target’
Rheumatologist Richard Brasington, MD, says patient John Reigstad’s active participation in treatment decisions shows how much improving quality of life matters
2014 ACR/ARHP Annual Meeting: Rheumatoid Arthritis Management Treatment Recommendations
The ACR shares highlights of in-development guidelines for RA combination strategies, live vaccines and biologics
Case Report: Rheumatoid Arthritis and Degenerative Disk Disease
Combination therapy includes abatacept for patient with erosive, chronic RA, underlying osteoarthritis and degenerative disk disease
- « Previous Page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- …
- 73
- Next Page »